PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Clinical trials for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill hopes to ease breathing in tough lung conditions
Disease control Recruiting nowThis study tests an experimental oral drug, ROC-101, in 40 adults with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (ILD-PH). Participants take the drug alongside their usual care for 24 weeks, with a long-term follow-up. The…
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: AllRock Bio, Inc. • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
Study offers ongoing TPIP access for lung hypertension patients
Disease control AVAILABLEThis study gives continued access to the inhaled drug TPIP for people with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (PH-ILD). Only those who finished earlier open-label studies of TPIP can join. The goal is to keep provid…
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 11, 2026 20:49 UTC